NEW YORK (Reuters Health) —Psoriasis patients who are new users of infliximab and adalimumab appear to be at a greater […]
Made-to-Order TILs Effective Against Metastatic Melanoma
In just over one third of patients with metastatic melanoma who had experienced disease progression while receiving multiple prior lines […]
EMA Advises Limited Use of Celltrion COVID-19 Antibody Drug, Says Benefits Still Unclear
(Reuters) – Europe’s drug regulator said on Friday South Korean drugmaker Celltrion’s COVID-19 treatment can be considered for patients at […]
Community Oncologists Balk at Home Chemo’s Financial Effects
This is the third in a series of articles on delivering cancer treatment at home. If providing cancer therapies at […]
IDSA Updates COVID-19 Treatment Guidelines: Monoclonals and More
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. While there is still no “game-changer” […]
Another HIV Tivicay Birth Outcome: Better Infant Survival
Infants born to women with HIV who were taking dolutegravir (DTG) plus emtracitabine/tenofovir alafenamide (FTC/TAF) had significantly higher odds of […]
EU Regulator Advises on Use of Lilly’s COVID-19 Antibody Cocktail
(Reuters) – Europe’s medicines regulator said on Friday Eli Lilly and Co’s antibody drug combination can be used to treat […]
No Benefit Seen With Everolimus in Early Breast Cancer
Adding everolimus to adjuvant hormone therapy for early ER+, HER2- breast cancer does not offer any benefit over hormone therapy […]
Adalimumab Earns FDA Approval for Ulcerative Colitis in Children
Adalimumab has received approval from the Food and Drug Administration for use in pediatric patients aged 5 years and older […]
Asthma Patients Say Most Doctors Don’t Ask About Cannabis Use
Among individuals with asthma and allergies who use cannabis, more than half said they aren’t willing to discuss their use […]